Ik. Barker et al., DETERMINATION OF ALTRETAMINE IN HUMAN PLASMA WITH HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 660(1), 1994, pp. 121-126
Citations number
10
Categorie Soggetti
Chemistry Analytical
Journal title
Journal of chromatography B. Biomedical applications
A fast, simple, and sensitive isocratic HPLC method has been developed
and validated for the determination of the anticancer drug altretamin
e in human plasma. Spiked serum samples and clinical plasma samples ar
e extracted with acetonitrile at 4 degrees C and the precipitate remov
ed by filtration. The plasma sample volume required (ca. 0.2 ml) is sm
all and the total analysis time is less than 15 min per sample (includ
ing batch-wise pre-treatment). Recovery of altretamine is 99 to 106% f
or pooled human serum spiked with altretamine in the range 200 ng/ml t
o 10 mg/ml. In this concentration range, the R.S.D. varies from 1 to 8
%. The limit of quantitation is ca. 150 ng/ml for an R.S.D. of 10%. Th
e intra-day R.S.D. for human samples spiked at 5 mg/ml varied between
1.7 and 4%; the inter-day R.S.D. at this concentration was ca. 3%. A p
reliminary study with one patient receiving 260 mg/m2 by mouth indicat
ed that the peak altretamine concentration was significantly lower aft
er a standard breakfast than in the fasting state.